Keyphrases
Fibromyalgia
100%
Ankylosing Spondylitis
91%
Familial Mediterranean Fever
84%
Psoriatic Arthritis
66%
COVID-19
65%
Israel
62%
Retrospective Cohort Study
61%
Ischemic Heart Disease
52%
Fibromyalgia Patients
51%
Health Care Services
50%
Rheumatoid Arthritis
49%
Systemic Lupus Erythematosus
46%
Inflammatory Bowel Disease
45%
Multivariate Analysis
42%
Big Data Analysis
42%
Ankylosing
42%
Giant Cell Arteritis
42%
Patients with Fibromyalgia
36%
Drug Therapy
31%
Risk Factors
30%
Health Maintenance Organizations
29%
Healthcare Database
29%
Systemic Lupus Erythematosus Patient
28%
Golimumab
28%
Proportion of Days Covered
28%
Adalimumab
28%
Secukinumab
28%
Methotrexate
28%
Comorbidity
27%
Real-world Population
26%
Life Studies
25%
Inflammation
25%
Logistic Regression Model
24%
Rituximab
24%
Psoriasis
24%
Socioeconomic Status
24%
Delayed Diagnosis
24%
Connective Tissue Disease
23%
Autoimmune Disease
23%
Treatment Impact
22%
Sacroiliitis
22%
Univariate Analysis
22%
TNF Inhibitors
22%
Biological Treatment
22%
Health Service Utilization
21%
Pneumonia Patients
21%
Drug Consumption
21%
Phosphorylcholine
21%
COVID-19 Pneumonia
21%
Pulmonary Embolism
21%
Medicine and Dentistry
Familial Mediterranean Fever
84%
Fibromyalgia
84%
Cohort Analysis
66%
Ankylosing Spondylitis
63%
Cross Sectional Study
60%
Retrospective Cohort Study
51%
COVID-19
49%
Apoplexy
45%
Ischemic Heart Disease
44%
Inflammatory Bowel Disease
42%
Rheumatoid Arthritis
42%
Psoriatic Arthritis
42%
Giant-Cell Arteritis
42%
Sarcoidosis
42%
Health Service
36%
Infection
25%
Rituximab
24%
Hazard Ratio
24%
Connective Tissue Disease
23%
Primary Health Care
23%
Sacroiliitis
22%
Disease Modifying Antirheumatic Drug
22%
Disease
22%
Pulmonary Hypertension
21%
Pulmonary Embolism
21%
Systematic Review
21%
Vitamin D
21%
Psoriasis
21%
Asthma
21%
Pericarditis
21%
Meta-Analysis
21%
Drug Megadose
21%
Delayed Diagnosis
21%
Behcet Disease
21%
Granulomatosis with Polyangiitis
21%
Nephrotic Syndrome
21%
Placebo-Controlled Study
21%
Musculoskeletal Pain
21%
Magnetic Resonance Imaging
21%
Systemic Lupus Erythematosus
21%
Heart Disease
21%
Neoplasm
21%
Venous Thromboembolism
21%
Tocilizumab
21%
Autonomic Nervous System
21%
Spondyloarthropathy
21%
Systemic Scleroderma
21%
Anodyne
21%
Apremilast
21%
Epileptic Seizure
21%